We found that the inhibition of the CBP/β-catenin axis mediated by ICG-001 in oral squamous cell carcinoma led to the downregulation of BIRC5, EZH2, AURKA, CCNA2, and other genes previously implicated in therapy resistance (Figure 5D). The gene discussed is BIRC5; the disease is oral cavity squamous cell carcinoma.